We use Google Analytics to count anonymous page views and understand which content gets read. No ads, no profiles. Decline keeps you on cookieless mode. Details.
Pure-play AI-driven drug-discovery platforms — generative biology, computational chemistry, antibody design, and protein-structure prediction applied to therapeutic pipelines. Companies where AI is the differentiator, not a buzzword bolted onto a traditional biotech. Seed members are 2026's 4 cleanest public listings on this thesis; the basket will grow as new IPOs land and Insitro-class private names go public.
source: editorial 2026-05-18